Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
11/2005
11/17/2005US20050256136 1-[2-(3-Ethyl-ureido)-3H-benzoimidazol-5-yl]-1H-imiazole-4-carboxylic acid methyl ester; bacteriostatic antibiotic; decrease antibiotic resistance of bacterial organisms; new class of compounds for bacterial infections
11/17/2005US20050256130 Substituted piperazines
11/17/2005US20050256124 Melanin-concentrating hormone receptor antagonists and compositions and methods related thereto
11/17/2005US20050256122 Substituted pyridazinones
11/17/2005US20050256120 Heterocyclo-substituted imidazoles for the treatment of inflammation
11/17/2005US20050256105 Protease inhibitors
11/17/2005US20050256104 Protease inhibitors
11/17/2005US20050256103 Indole derivative having piperidine ring
11/17/2005US20050256100 Protease inhibitors
11/17/2005US20050256099 Selected CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions
11/17/2005US20050256066 Fredericamycin derivatives
11/17/2005US20050256034 Dioxolane analogs for improved inter-cellular delivery
11/17/2005US20050256000 Quinoxalin-2-one derivatives, compositions which protect useful plants and comprise these derivatives, and processes for their preparation and their use
11/17/2005US20050255475 Energy transfer dyes, terminators and use thereof
11/17/2005DE102004018953A1 4-Halogenalkylpyridin-3-sulfonsäureamide, Verfahren zu ihrer Herstellung, sie enthaltende Mittel und ihre Verwendung als Schädlingsbekämpfungsmittel 4-haloalkylpyridine-3-sulfonamides, process for their preparation, compositions containing them and their use as pesticides
11/17/2005CA2566096A1 Piperazine derivatives of alkyl oxindoles
11/17/2005CA2565843A1 Novel compounds of proline and morpholine derivatives
11/17/2005CA2565630A1 Pyrrolidin-2-one and piperidin-2-one derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors
11/17/2005CA2564986A1 Pyrrole or imidazole amides for treating obesity
11/16/2005EP1594867A2 Phenylacetamides and their use as glucokinase modulators
11/16/2005EP1594864A1 Benzofuran oxyethylamines serving as antidepressant drugs and anxiolytic drugs
11/16/2005EP1594861A1 Triazole compounds and the therapeutic use thereof
11/16/2005EP1594860A2 Library of biphenyl derivatives useful for identifying compounds having both beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity
11/16/2005EP1594858A2 Novel benzoimidazole derivatives useful as antiproliferative agents
11/16/2005EP1594847A2 Substituted azole derivatives as therapeutic agents
11/16/2005EP1594840A1 Piperidine-benzenesulfonamide derivatives
11/16/2005EP1594505A2 Phenylglycine derivatives useful as serine protease inhibitors
11/16/2005EP1594501A2 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
11/16/2005EP1379516B1 Alkoxycarbonylamino benzoic acid or alkoxycarbonylamino tetrazolyl phenyl derivatives as ip antagonists
11/16/2005EP1370557B1 Benzimidazole anti-inflammatory compounds
11/16/2005EP1363631A4 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
11/16/2005EP1326850B1 A process for the preparation of bis-benzazolyl compounds
11/16/2005EP1317442B1 Quinolinone derivatives as tyrosine kinase inhibitors
11/16/2005EP1257550B1 Platelet adp receptor inhibitors
11/16/2005EP1237865B1 A factory scale process for producing crystalline atorvastatin trihydrate hemi calcium salt
11/16/2005EP1222182B1 Substituted (aminoiminomethyl or aminomethyl) dihydrobenzofurans and benozopyrans
11/16/2005EP1218374B1 Pharmaceutically active sulfonamide derivatives
11/16/2005CN1696129A Novel process for the synthesis of carboxylic acid phenylamide
11/16/2005CN1227244C Herbicidal benzoyl derivatives
11/16/2005CN1227236C Substituted imidazole neuropeptide YY5 receptor antagonists
11/16/2005CN1227228C Delta 1-pyrrolines used as pesticides
11/15/2005US6965036 Intermediates for guanidine mimics as factor Xa inhibitors
11/15/2005US6964983 Compounds that modulate PPAR activity and methods for their preparation
11/15/2005US6964977 E.g., 5-(((Z)-(2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl)-amino)-1,3-dihydro-2H -benzimidazol-2-one; inhibition or antagonism of protein kinases; treating pain or cancer
11/15/2005US6964974 2,3-oxidosqualene-lanosterol cyclase inhibitors
11/15/2005US6964973 Nonsteroidal agonists and antagonists
11/15/2005US6964968 Respiratory system disorders; cardiovascular disorders; viricides
11/15/2005US6964967 Substituted pyrido[2,3-d]pyrimidines and methods for their use
11/15/2005CA2330351C New linear or cyclical ureas, their preparation process and the pharmaceutical compositions which contain them
11/15/2005CA2248802C Meso-substituted tripyrrane compounds, compositions, and methods for making and using the same
11/15/2005CA2179640C Watersoluble azole antifungals
11/10/2005WO2005105790A1 4- 2- (cycloalkylamino) pyrimidin-4-yl ! - (phenyl) - imidazolin-2- one derivatives as p38 map- kinase inhibitors for the treatment of inflammatory diseases
11/10/2005WO2005105778A2 4-amino-5-cyanopyrimidine derivatives
11/10/2005WO2005105776A1 Arylsulfonyl benzodioxanes useful for modulation the 5-ht6 receptor, the 5-ht2areceptor or both
11/10/2005WO2005105770A2 Arylphenylamino-, arylphenylamide-, and arylphenylether-sulfide derivatives
11/10/2005WO2005105761A1 Morpholinylanilinoquinazo- line derivatives for use as antiviral agents
11/10/2005WO2005105760A1 Heterocyclic amide compound and use thereof as an mmp-13 inhibitor
11/10/2005WO2005105758A1 Tri-substituted ureas as cytokine inhibitors
11/10/2005WO2005105757A1 Tri-substituted ureas as cytokine inhibitors
11/10/2005WO2005105753A2 Naphthalimide derivatives, methods for their production and pharmaceutical compositions therefrom
11/10/2005WO2005105752A1 Novel phenantridine analogues and their uses as inhibitors of hyperproliferation of t cells and/or keratinocytes
11/10/2005WO2005105748A1 4-halogenalkylpyridin-3-sulphonamides, method for producing same, agents containing same, and use thereof as agents for pest control
11/10/2005WO2005105743A1 Nitrogen-containing heterocyclic compounds and medicinal use thereof
11/10/2005WO2005105110A2 Doxepin analogs and methods of use thereof
11/10/2005WO2005105079A2 Novel imidazoles
11/10/2005WO2005105075A1 Tri-substitued 2-benzhydryl-5-benzlamino-tetrahydro-pyran-4-ol and 6-benzhydryl-4-benzylamino-tetrahydro-pyran-3-ol analogues, and novel 3,6-disubstituted pyran derivatives
11/10/2005WO2005095326A3 2-amino- and 2-thio-substituted 1,3-diaminopropanes
11/10/2005WO2005092867A3 Process and intermediate compounds useful in the preparation of statins, particularly rosuvastatin
11/10/2005WO2005075429B1 Novel quinoline-carbaxamides as jack3 kinase modulators
11/10/2005US20050250945 Triazine compounds as inhibitors of bacterial type III protein secretion systems
11/10/2005US20050250943 Arylsulfonyl benzodioxanes, benzoxazines and benzothiazines as 5-HT6 antagonists
11/10/2005US20050250846 Non-peptide GnRH agents, pharmaceutical compositions and methods for their use
11/10/2005US20050250835 Novel tumor-selective chemotherapeutic agents
11/10/2005US20050250812 Methods for treating lewy body dementia
11/10/2005US20050250810 Screening for an enzyme inhibitor of Fab I or Fab K using providing a reaction mixture comprising Fab I or Fab K, crotonyl-ACP and NAPDH or NADH; contacting a candidate compound with the reaction mixture; and detecting inhibition of Fab I or Fab K; bactericides; fungicides; antibiotics; Stapylococcus
11/10/2005US20050250807 Neurotrophin antagonist compositions
11/10/2005US20050250797 Quinzoline derivatives for use in the treatment of cancer
11/10/2005US20050250792 Substituted piperidine compounds useful as modulators of chemokine receptor activity
11/10/2005US20050250789 Hydroxamic acid derivatives as metalloprotease inhibitors
11/10/2005US20050250786 PNA monomer and precursor
11/10/2005US20050250785 PNA monomer and precursor
11/10/2005US20050250774 N-{2-[2-(3,4-Dimethoxy-phenyl)-ethoxy]-6-morpholin-4-yl-pyridin-4-yl}-N'-(1 H-indol-3-ylmethylene)-hydrazine; interleukin IL-12 overproduction-related disorder; antiinflammatory agent; autoimmune diseases: multiple sclerosis, sepsis, neuropathies, cirrhosis, hepatitis, diabetes, arthritis
11/10/2005US20050250770 Fused heterocyclic compounds
11/10/2005US20050250769 5-Methyl-1-(tetrahydro-pyran-2-ylmethyl)-2-(4-trifluoromethoxy-phenyl)-1H-imidazole-4-carboxylic acid piperidin-1-ylamide; CB1 receptor modulation; obesity; antidiabetic agents;anxiolytic agents; psychosis; schizophrenia; antidepressants; drug abuse/dependance; multiple sclerosis; headaches; antieleptic
11/10/2005US20050250741 non-steroidal agonists and antagonists; 2-(2-ethylsulfanyl-1-hydroxy-1-methyl-ethyl)-6-trifluoromethyl-1H-indole-5--carbonitrile; anticarcinogenic; prostate carcinoma, benign prostatic hyperplasia (BPH), hirsutism, alopecia, anorexia nervosa, breast cancer, acne, AIDS, cachexia, as a male contraceptive
11/10/2005US20050250707 HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
11/10/2005US20050249675 Mucin synthesis inhibitors
11/10/2005US20050247001 Building block forming a c-c or a c-hetero atom bond uponreaction
11/10/2005DE4303335B4 Ferroelektrische Flüssigkristall-Mischungen mit kurzer ferroelektrischer Ganghöhe A ferroelectric liquid crystal mixtures with a short pitch ferroelectric
11/10/2005CA2566196A1 Arylsulfonyl benzodioxanes useful for modulating the 5-ht6 receptor, the 5-ht2a receptor or both
11/10/2005CA2564589A1 Tri-substituted ureas as cytokine inhibitors
11/10/2005CA2564587A1 Tri-substituted ureas as cytokine inhibitors
11/10/2005CA2564175A1 Chemical compounds
11/10/2005CA2564085A1 Heterocyclic amide compound and use thereof as an mmp-13 inhibitor
11/10/2005CA2563222A1 Novel imidazoles
11/10/2005CA2563161A1 Tri-substitued 2-benzhydryl-5-benzylamino-tetrahydro-pyran-4-ol and 6-benzhydryl-4-benzylamino-tetrahydro-pyran-3-ol analogues, and novel 3,6-disubstited pyran derivatives
11/10/2005CA2562400A1 Novel phenantridine analogues and their uses as inhibitors of hyperproliferation of t cells and/or keratinocytes
11/10/2005CA2562176A1 Arylphenylamino-, arylphenylamide-, and arylphenylether-sulfide derivatives
11/10/2005CA2555718A1 Naphthalimide derivatives for the treatment of cancer
11/09/2005EP1593679A1 3- Or 4-monosubstituted phenol derivatives useful as H3 ligands
1 ... 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 ... 694